67
Views
21
CrossRef citations to date
0
Altmetric
Article

Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines

, &
Pages 882-885 | Received 31 Jan 2003, Accepted 22 Mar 2003, Published online: 08 Jul 2009

References

  • Chen ZX, Xue YQ, Zhang R. A clinical and experimental study on all-trans retinoic acid-treated acute polymyelocytic leukemia patients. Blood 1991;78:1413–9.
  • Zhao Z, Zhang ZP, Soprano DR, Soprano KJ. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Exp Cell Res 1995;219:555–61.
  • Fitzgerald P, Teng M, Chandraratna RA, Heyman RA, Allegretto EA. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status. Cancer Res 1997;57:2642–50.
  • Chytl F. Retinoic acid: biochemistry, pharmacology, toxicology and therapeutic use. Pharmacol Rev 1984;36:93–100.
  • Orfanos CE, Ehlert R, Gollnick H. The retinoids: a review of their clinical, pharmacology and therapeutic use. Drugs 1987;34: 459–503.
  • Lointier P, Wargovich MJ, Saez S, Levin B, Wildrik DM, Boman BM. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res 1987;7:817–22.
  • Eisman JA, Barkla DH, Tutton PJ. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25 dihydroxy vitamin D3. Cancer Res 1987;47: 21–5.
  • Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989; 1: 181–91.
  • Lointier P, Meggouh F, Dechelotte F, Pezet D, Ferrier CH, Chipponi J, et al. 1,25 dihydroxy vitamin D3 receptors and human colon adenocarcinoma. Br J Surg 1991;78:435–9.
  • Pols HAP, Birkenhäger JC, Foekens JA, van Leeuwen JPTM. Vitamin D analogues: from molecule to clinical application. Clin Endocrinol 1994;40:285–91.
  • Kawa S, Kaname Y, Masuo T, Haruhiko I, Hisao O, Kendo K, et al. Inhibitory effect of 22-Oxa-1,25 dihydroxyvitamin-D3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 1996;110:1605–13.
  • Colston KW, James SY, Oofori-Kuragu EA, Binderup L, Grant AG. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and vitro. Br J Cancer 1997;76:1017–20.
  • Colston KW, MacCray AG, James SY, Binderup L, Chander S, Coombes RC. EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 1992;44:2273–80.
  • Binderup L, Carlberg C, Kissmeyer AM, Latini S, Mathiasen IS, Hansen CM. The need for new vitamin D analogues: mechanisms of action and clinical applications. In: Norman AW, Bouillon R, Thomasset M, editors. Vitamin D: a pluripotent steroid hormone. Proceedings of the 9th Workshop on Vitamin D, Orlando, Florida, USA. Berlin: de Gruyter; 1994. p. 55–63.
  • Dore BT, Uskovic MR, Momparler RL. Interaction of retinoic acid and vitamin D3 analogues on HL-60 myeloid leukemic cells. Leuk Res 1993;17: 749–57.
  • Bollag W, Peck R. Cancer chemotherapy by combination of retinoids with cytokines and vitamin D analogues. Experimental and clinical results. Ann Oncol 1994;5:17–22.
  • Lutzky J, Vujicic M, Binderup L, Bhalla K. Vitamin D analogues and retinoids exhibit additive cytotoxicity to human myeloma cell lines. Proc Am Assoc Cancer Res 1994;35:408.
  • Zugmaier G, Jäger R, Grage B, Gottardis MM, Havemann K, Knabbe C. Growth-inhibitory effect of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 1996;73: 1341–6.
  • Kline K, Cochran GS, Sanders BG. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr Cancer 1990;14:27–41.
  • Arya P, Alibhai N, Qin H, Burton GW, Batist G, You SX, et al. Design and synthesis of analogs of vitamin E: antiproliferative activity against human breast adenocarcinoma cells. Bioorg Med Chem Lett 1998;8:2433–8.
  • Heisler T, Towfigh S, Simon N, Liu C, McFadden DW. Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth. J Surg Res 2000;88:23–5.
  • Malafa MP, Neitzel LT. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000;93:163–70.
  • Sigounas G, Anagnostou A, Steiner M. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 1997;28:30–5.
  • Appel MJ, van Garderen-Hoetmer A, Woutersen RA. Lack of inhibitory effects of beta-carotene, vitamin C, vitamin E and selenium on development of ductular adenocarcinomas in exocrine pancreas of hamsters. Cancer Lett 1996;103:157–62.
  • Rautalahti MT, Virtamo JR, Taylor PR, Heinonen OP, Albanes D, Haukka JK, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomised, controlled trial. Cancer 1999;86:37–42.
  • Woutersen RA, Appel MJ, Van Garderen-Hoetmer A. Modulation of pancreatic carcinogenesis by antioxidants. Food Chem Toxicol 1999;37:981–4.
  • Sata N, Klonowski-Stumpe H, Han B, Haussinger D, Niederau C. Menadione induces both necrosis and apoptosis in rat pancreatic acinar AR4–2 J cells. Free Radic Biol Med 1997;23:844–50.
  • Kar S, Carr BI. Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin. J Cell Physiol 2000;185:386–93.
  • Osada S, Saji S, Osada K. Critical role of extracellular signalregulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. Cancer 2001;91: 1156–65.
  • Liao WC, Wu FY, Wu CW. Binary/tertiary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CGI cells. Int J Oncol 2000;17: 323–8.
  • Albrechtsson E, Ohlsson B, Axelson J. The expression of retinoic acid receptors and the effects in vitro by retinoids in human pancreatic cancer cell lines. Pancreas 2002;25:49–56.
  • Albrechtsson E, Jonsson T, Möller S, Höglund M, Ohlsson B, Axelson J. The vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases the cell number. Pancreatology 2003;3: 41–6.
  • Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods 1991;142: 257–65.
  • Monstein H-J, Ohlsson B, Axelson J. Differential expression of gastrin, cholecystokinin-A, and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. Scand J Gastroenterol 2000;36:738–43.
  • Balaz P, Friess H, Buchler MW. Growth factors in pancreatic health and disease. Pancreatology 2001;1:343–55.
  • Rosewics S, Stier U, Brembeck F, Kaiser A, Papadimitriou CA, Berdel WE, et al. Retinoids: Effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995;109:1646–60.
  • Bold RJ, Ishizuka J, Townsend CM, Thompson JC. All-transretinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas 1996;12:189–95.
  • Bestervelt L, Barr B, Dethloff L. Divergent proliferative responses to a gastrin receptor ligand in synchronised and unsynchronised rat pancreatic AR42 J tumour cells. Cell Signal 2000;12: 53–61.
  • Wenger FA, Jacobi CA, Kilian M, Zieren HU, Muller JM. Does dietary alpha-linolenic acid promote liver metastases in pancreatic carcinoma initiated by BOP in Syrian hamsters? Ann Nutr Metab 1999;43:121–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.